Clinical Trial Update: A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing docetaxel monotherapy to DOXIL plus docetaxel in patients with advanced breast cancer; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxil (liposomal doxorubicin)
• Taxotere (docetaxel) (docetaxel)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2012-10-02